In conclusion, the results of the present study suggested that liraglutide, insulin, and their combination improved hepatic inflammation, oxidative stress status, and apoptosis in an STZ-induced T1DM mouse model, which appears to be associated with activation of the Wnt/β-catenin signaling pathway. Here, INS is linked to type 1 diabetes mellitus.